Abstract:Abstract Background: Acute kidney injury (AKI) is a common clinical disease with complex pathophysiology and very limited therapeutic choices. This prompts the need for novel therapy targeting multiple aspects of this disease. Human amnion epithelial cells (hAECs) are ideal alternative stem cell source for regenerative medicine. Increasing evidence suggests that hAEC-derived exosomes (hAECs-EXO) may act as novel cell–cell communicators. Accordingly, we assessed the therapeutic potential of hAECs in ischemia reperfusion mouse model of AKI and explored the underlying mechanisms.Methods: The hAECs were primary cultured and hAECs-EXO were isolated and characterized. An ischemic renal injury mouse model was established to mimic different severity of the kidney injury. Mouse blood creatinine level was used to assess renal function and kidney specimens were processed to detect cell proliferation, apoptosis and angiogenesis. Immune cells infiltration was analyzed by flow cytometry. hAECs-EXO was used to treat hypoxia-reoxygenation (H/R) injured HK2 cells and mouse bone marrow-derived macrophages to evaluate their protective effect in vitro. Furthermore, hAEC exosomes were subjected to liquid chromatography-tandem mass spectrometry for proteomic profiling. Results: We found that systematically administered hAECs could improve mortality and renal function in IRI mice; decrease the number of apoptotic cells; promote peritubular capillary regeneration and modulate kidney local immune response. However, hAECs showed very low kidney tissue integration. Exosomes isolated from hAECs recapitulated the renal protective effects of their parent cells. In vitro, hAECs-EXO protected HK-2 cells from H/R injury-induced apoptosis and promoted bone marrow-derived macrophage polarization toward M2 phenotype. Proteomic analysis on hAECs-EXO revealed proteins involved in extracellular matrix organization, growth factor signaling pathways, cytokine production and immunomodulation. These findings demonstrated that paracrine of exosomes might be a key mechanism by hAECs mediating kidney functional recovery in AKI.Conclusions: We first reported hAECs could improve mortality and renal repair in mice with ischemia-reperfusion injury. The anti-apoptotic, pro-angiogenetic, and immunomodulatory capabilities of hAECs at least partially, through paracrine pathways. The renoprotective effects of hAECs-EXO might be a promising clinical therapeutic tool, overcoming the weaknesses and risks associated with the use of native stem cells for patients with AKI.

Combined lineage tracing and scRNA‐seq reveal the activation of Sox9+ cells in renal regeneration with PGE2 treatment

Renal subcapsular delivery of PGE2 promotes kidney repair by activating endogenous Sox9+ stem cells

Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.

Activated SOX9+renal Epithelial Cells Promote Kidney Repair Through Secreting Factors

Transient upregulation of EGR1 signaling enhances kidney repair by activating SOX9 + renal tubular cells

Sox 9 activation is involved in tubule repair after unilateral partial nephrectomy

In vivo two-photon microscopy reveals the contribution of Sox9+ cell to kidney regeneration in a mouse model with extracellular vesicle treatment

SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys

Effect of selective inhibition or activation of PGE2 EP1 receptor on glomerulosclerosis

WT1+ Glomerular Parietal Epithelial Progenitors Promote Renal Proximal Tubule Regeneration after Severe Acute Kidney Injury

Notch-mediated Sox9+ Cell Activation Contributes to Kidney Repair after Partial Nephrectomy

Exosomal let-7b-5p deriving from parietal epithelial cells attenuate renal fibrosis through suppression of TGFβR1 and ARID3a in obstructive kidney disease

Adipose-derived Mesenchymal Stem Cells Employed Exosomes to Attenuate AKI-CKD Transition Through Tubular Epithelial Cell Dependent Sox9 Activation.

Single-cell dissection of cellular and molecular features underlying mesenchymal stem cell therapy in ischemic acute kidney injury

Human Amniotic Epithelial Cells Improve Kidney Repair in Ischemia-Reperfusion Mouse Model of Acute Kidney Injury

R2: identification of renal potential progenitor/stem cells that participate in the renal regeneration processes of kidney allograft fibrosis.

Sox17 is Required for Endothelial Regeneration Following Inflammation-Induced Vascular Injury

Tubular epithelial cells-derived small extracellular vesicle-VEGF-A promotes peritubular capillary repair in ischemic kidney injury

Generation of Renal Tubular Organoids from Adult SOX9+ Kidney Progenitor Cells

Renal Interstitial Cells Promote Nephron Regeneration by Secreting Prostaglandin E2

Isolation and long-term expansion of a single adult human renal epithelial cell with efficient kidney regeneration capacity